Sio Capital Management’s NextCure NXTC Stock Holding History

Sio Capital Management’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,940	Closed	-$155K	–	86
2025 Q4	$155K	Hold	10,940	–	–	0.02%	66
2025 Q3	$64.1K	Sell	10,940 -2	-0%	-$10	0.02%	49
2025 Q2	$60.4K	Buy	10,942 +109	+1%	+$585	0.02%	48
2025 Q1	$62.4K	Hold	10,833	–	–	0.02%	51
2024 Q4	$100K	Hold	10,833	–	–	0.03%	47
2024 Q3	$178K	Hold	10,833	–	–	0.07%	35
2024 Q2	$207K	Hold	10,833	–	–	0.06%	44
2024 Q1	$290K	Hold	10,833	–	–	0.09%	46
2023 Q4	$148K	Hold	10,833	–	–	0.03%	38
2023 Q3	$168K	Hold	10,833	–	–	0.05%	46
2023 Q2	$234K	Hold	10,833	–	–	0.06%	39
2023 Q1	$192K	Hold	10,833	–	–	0.1%	39
2022 Q4	$183K	Hold	10,833	–	–	0.07%	41
2022 Q3	$358K	Hold	10,833	–	–	0.11%	40
2022 Q2	$611K	Hold	10,833	–	–	0.23%	48
2022 Q1	$632K	Hold	10,833	–	–	0.21%	51
2021 Q4	$780K	Buy	+10,833	New	+$906K	0.24%	57

Other funds holding NXTC

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

EAM

Exome Asset Management New York $162M AUM 259.04% 1-Year Est. Return

Sio Capital Management's NXTC Position: Q1 2026 in Review

Sio Capital Management sold out of NextCure (NXTC) in Q1 2026, closing a stake of 10,940 shares — an estimated $155K sold.

Sio Capital Management first reported a position in NXTC in Q4 2021 and held it in 17 quarters. The position peaked at $780K in Q4 2021. 26 funds tracked by Wall St. Rank hold NXTC as of Q1 2026.

Sio Capital Management reported no remaining NextCure position as of Q1 2026 after selling out during the quarter.
Sio Capital Management sold 10,940 NextCure shares in Q1 2026, an estimated $155K.
Sio Capital Management first reported a position in NextCure in Q4 2021 and held it in 17 quarters.
Sio Capital Management's NextCure position peaked at $780K in Q4 2021.
26 funds tracked by Wall St. Rank held NextCure as of Q1 2026.

Based on Sio Capital Management's 13F filing for Q1 2026, filed 14 May 2026.